The tenth SpaceX cargo resupply launch to the International Space Station, targeted for launch Feb. 18, will deliver investigations that study human health, Earth science and weather patterns. Here are some highlights of the research headed to the orbiting laboratory:
Crystal growth investigation could improve drug delivery, manufacturing
Monoclonal antibodies are important for fighting off a wide range of human diseases, including cancers. These antibodies work with the natural immune system to bind to certain molecules to detect, purify and block their growth. The Microgravity Growth of Crystalline Monoclonal Antibodies for Pharmaceutical Applications (CASIS PCG 5) investigation will crystallize a human monoclonal antibody, developed by Merck Research Labs, that is currently undergoing clinical trials for the treatment of immunological disease.
>> Read the Full Article